Erdafitinib 3mg Tablet

$257.00
Composition: Erdafitinib 📦 28 Tablets per Box Manufacturer/Trademark: Natco Pharma
Strength:
Genuine Stock
Export Docs
Discreet Pack
3+ sold in last 7 days
Qty:
Prescription Medicine This product requires a valid prescription. Please consult your physician before use and follow their guidance on dosage and administration.

Erdafitinib 3mg Tablet (Generic Balversa 3mg® 3mg)

Erdafitinib 3mg Tablet (Erdanat 3mg) is a prescription fibroblast growth factor receptor (FGFR) inhibitor used to treat adults with susceptible FGFR3 genetic alterations in locally advanced or metastatic urothelial carcinoma (bladder cancer). Generic equivalent of Balversa® (Janssen) and widely used as targeted cancer therapy under specialist supervision. Buy from a trusted supplier with worldwide shipping where permitted.

Product Information

  • Generic Name: Erdafitinib 3mg
  • Drug Class: Fibroblast Growth Factor Receptor (FGFR) Inhibitor; Targeted Anticancer Agent
  • Brand Reference: Balversa® (Janssen)
  • Indication: Locally advanced or metastatic urothelial carcinoma with susceptible FGFR3 genetic alterations
  • Form: Oral Tablet
  • Strength: 3mg
  • Packing: 28 Tablets per Box
  • Route: Oral
  • Prescription: Yes
  • Evidence: FDA-approved; EMA approvals and regional indications vary

How It Works

Erdafitinib selectively inhibits fibroblast growth factor receptors (FGFRs), particularly FGFR2 and FGFR3, which may drive the growth of certain cancers. By blocking these signaling pathways, Erdafitinib helps slow tumor growth and disease progression in patients with eligible FGFR genetic alterations. Genetic testing is typically required before treatment.

Availability & Ordering

Patients and healthcare professionals searching for Erdafitinib 3mg Tablet, Buy Erdafitinib Online, Generic Balversa® 3mg, Erdafitinib Price USA UK, FGFR Inhibitor, and Bladder Cancer Targeted Therapy will find genuine stock available for worldwide shipping where permitted by local import regulations. All orders are securely dispatched. Prescription medicines should only be used under the supervision of a qualified healthcare professional.

Frequently Asked Questions

What is Erdafitinib 3mg used for?

Erdafitinib is used to treat adults with locally advanced or metastatic urothelial carcinoma that has susceptible FGFR genetic alterations.

Is Erdafitinib the same as Balversa®?

Yes. Balversa® is the reference brand manufactured by Janssen. Generic Erdafitinib contains the same active pharmaceutical ingredient.

How does Erdafitinib work?

Erdafitinib blocks FGFR proteins involved in cancer cell growth and spread, helping slow disease progression in eligible patients.

Do I need genetic testing before taking Erdafitinib?

Yes. Treatment is generally recommended only after confirming eligible FGFR genetic alterations using an approved diagnostic test.

Is Erdafitinib available internationally?

Yes. Erdafitinib 3mg Tablet is available for worldwide shipping where permitted by local regulations.

Last Updated: July 31, 2026 | Medically Reviewed By: Licensed Pharmacist

Medical Disclaimer: This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting or changing any prescription medication.

Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.

Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.

All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.

Reviews

There are no reviews yet

Add a review
Currently, we are not accepting new reviews
More products with Erdafitinib
View all Erdafitinib →
Related Products

Health Tips & Exclusive Offers

Subscribe for new products, weekly deals & members-only discounts

Added to Cart! Item added successfully